Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01311830 · ClinicalTrials.gov registry record · NA
Enhancing Smoker Utilization of the Minnesota Quitline Through Support Persons
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 534
- Enrollment target
NCT01311830: Completed NA study, sponsored by Mayo Clinic.
NCT01311830 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 534 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (62% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01311830, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 534 participants
- Enrollment target
Study Summary
This study will develop an intervention for adults who want to support a smoker. The goal of the intervention is for the support person to motivate \& encourage their smoker to call the state Quitline funded by Minnesota ClearWay. The study will examine the efficacy of a telephone based intervention for support persons compared to a self-help intervention (written materials only).
Interventions
- BEHAVIORAL Written Materials
- BEHAVIORAL Telephone Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 534 participants |
| Start Date | 2007-09 |
| Est. Completion | 2010-04 |
| Phase | NA |
What the finished NCT01311830 record still lists
NCT01311830 is an interventional study that assigns participants to a tested intervention. The registered 534 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (62% lower).
The record links to 0 conditions, and to 2 interventions - of which Written Materials is the first listed.
NCT01311830 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01311830 about?
NCT01311830 is a clinical study titled "Enhancing Smoker Utilization of the Minnesota Quitline Through Support Persons". This study will develop an intervention for adults who want to support a smoker. The goal of the intervention is for the support person to motivate \& encourage their smoker to call the state Quitline funded by Minnesota ClearWay. The study will examine the efficacy of a telephone based intervention...
What is the current status of trial NCT01311830?
This trial is currently completed. It is a NA study. The enrollment target is 534 participants. The study started on 2007-09. Estimated completion is 2010-04.
What interventions are being tested in trial NCT01311830?
The interventions under investigation include: Written Materials (BEHAVIORAL), Telephone Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT01311830?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01311830's enrollment target sits among peer trials
534 188th of 2000 higher than 1,813 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04910685 · 534 participants · Phase 2
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
- NCT06128551 · 534 participants · Phase 1
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- NCT05614739 · 535 participants · Phase 1
FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
- NCT07091617 · 535 participants · NA
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia